📈 New purchase - CapsoVision

I am with CapsoVision an innovative MedTech company that is setting new standards with its 360° capsule endoscopy. No external recorder required, full perspective - and already FDA-approved & in use in the USA.

💡 Why this investment?

• Technological advantage compared to traditional solutions (e.g. PillCam from Medtronic)
• Already cooperating with Pentax Medical
• Focus on early detection & diagnosticsa megatrend in the healthcare sector
• Low market capitalization (~180m USD) with a lot of upside potential

🚀 Vision:

If CapsoVision reaches USD 50-100m sales in the medium term, a multiple in the share price is possible. In the long term I see 10-25 USD+ per share as realistic - depending on market penetration and access to capital, of course.

I think: exciting small cap story with disruptive potential - What do you think?

👉 Do you know the company? How do you rate the opportunities & risks?

Please leave your opinion!

#aktien
#investieren
#MedTech
#CapsoVision
#SmallCap
#langfristig
#innovation
#getquin
#medizin
#medizintechnik
#pharma
#medical
#zukunft
$NOVO B (+4,84 %)
$PLTR (+3,08 %)
$AMD (-0,05 %)
$NOVN (+0,68 %)

Hey community 👋 do you already know CapsoVision Inc.a newly listed MedTech company with a focus on capsule endoscopy and AI-supported diagnostics?

The company is developing capsules that patients can swallow to examine the small intestine or, in future, the large intestine -> non-invasively.

This capsule is approved worldwide, wireless incl. 360° panorama.

IPO was completed on July 3, 2025.

Some figures:

Turnover (TTM) approx. USD 12 million

YoY growth +38 %

Gross margin 63 %

Loss (TTM) approx. USD -21 million

EV/Sales approx. 16×

Cash after IPO ~26m USD

Of course, this is not a dividend stock - high losses, high expectations, but also:

✅ Real product on the market

✅ Innovation with AI potential

✅ Good gross margin & sales growth

✅ Just went public → plenty of room for discovery

👉 I'm curious to see whether CapsoVision will become a success story à la "MedTech Hidden Champion" in 2-3 years - or whether it will remain an attempt.

What do you think?

$CV
#ipo
#medtech
#medizin
#health
#gesundheit
#aktie
#nasdaq
#medical
#gesund
#pharma
#international
#getquin
#deutschland
#österreich
#schweiz
#usa